{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:09:42Z","timestamp":1784196582655,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10014-025-00518-y","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:12:48Z","timestamp":1760083968000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential"],"prefix":"10.1007","volume":"43","author":[{"given":"Bin","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Ka Seng","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"518_CR1","first-page":"179","volume-title":"Who classification of tumours: soft tissue and bone tumours","author":"Who Classification of Tumours Editorial Board","year":"2020","unstructured":"Who Classification of Tumours Editorial Board (2020) Glomus tumour. Who classification of tumours: soft tissue and bone tumours. Iarc, Lyon, pp 179\u2013181"},{"key":"518_CR2","first-page":"32491428","volume-title":"Statpearls","author":"O Mohammadi","year":"2023","unstructured":"Mohammadi O, Suarez M (2023) Glomus cancer. Statpearls. Statpearls Publishing, Treasure Island, p 32491428"},{"issue":"1","key":"518_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/01913128409141853","volume":"7","author":"Sl Asa","year":"1984","unstructured":"Asa Sl, Kovacs K, Horvath E, Ezrin C, Weiss Mh (1984) Sellar glomangioma. Ultrastruct Pathol 7(1):49\u201354","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"518_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-005-1006-8","volume":"110","author":"D H\u00e4nggi","year":"2005","unstructured":"H\u00e4nggi D, Adams H, Hans Vh, Probst A, Tolnay M (2005) Recurrent glomus tumor of the sellar region with malignant progression. Acta Neuropathol 110(1):93\u201396","journal-title":"Acta Neuropathol"},{"issue":"4","key":"518_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12022-011-9179-2","volume":"22","author":"JO Ebinu","year":"2011","unstructured":"Ebinu JO, Shahideh M, Ibrahim GM et al (2011) Sellar glomangioma. Endocr Pathol 22(4):218\u2013221","journal-title":"Endocr Pathol"},{"issue":"4","key":"518_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/1066896919900550","volume":"28","author":"J Tsang","year":"2020","unstructured":"Tsang J, Ng Cs, Fung Cf, Chan J, Cheuk W (2020) Glomus tumor of sella turcica with synaptophysin expression mimicking pituitary adenoma. Int J Surg Pathol 28(4):401\u2013405","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"518_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00428-020-02923-4","volume":"478","author":"Bl Quah","year":"2021","unstructured":"Quah Bl, Donofrio Ca, La Rosa S et al (2021) Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm. Virchows Arch 478(5):977\u2013984","journal-title":"Virchows Arch"},{"issue":"9","key":"518_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.5858\/2008-132-1448-GT","volume":"132","author":"Z Gombos","year":"2008","unstructured":"Gombos Z, Glomus PJ (2008) Glomus tumor. Arch Pathol Lab Med 132(9):1448\u20131452","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"518_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jcot.2016.04.006","volume":"7","author":"Vm Morey","year":"2016","unstructured":"Morey Vm, Garg B, Kotwal Pp (2016) Glomus tumours of the hand: review of literature. J Clin Orthop Trauma 7(4):286\u2013291","journal-title":"J Clin Orthop Trauma"},{"issue":"12","key":"518_CR10","first-page":"889","volume":"50","author":"L Jiang","year":"2014","unstructured":"Jiang L, Shi J, Liu W, Kang J, Wang N (2014) Clinical feature of chronic compressive optic neuropathy without optic atrophy. Zhonghua Yan Ke Za Zhi 50(12):889\u2013893","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"518_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00000478-200203000-00003","volume":"26","author":"M Miettinen","year":"2002","unstructured":"Miettinen M, Paal E, Lasota J et al (2002) Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 26:301\u2013311","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"518_CR12","first-page":"V05180331","volume":"181","author":"MW M\u00f8ller","year":"2019","unstructured":"M\u00f8ller MW, Andersen MS, Glintborg D et al (2019) Pituitary adenoma. Ugeskr Laeger 181(20):V05180331","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"518_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"Sl Asa","year":"2022","unstructured":"Asa Sl, Mete O, Perry A, Osamura Ry (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33(1):6\u201326","journal-title":"Endocr Pathol"},{"issue":"6","key":"518_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MED.0000000000000293","volume":"23","author":"Bk Kleinschmidt-Demasters","year":"2016","unstructured":"Kleinschmidt-Demasters Bk (2016) Histological features of pituitary adenomas and sellar region masses. Curr Opin Endocrinol Diabetes Obes 23(6):476\u2013484","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"518_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12022-018-9521-z","volume":"29","author":"Sl Asa","year":"2018","unstructured":"Asa Sl, Mete O (2018) Immunohistochemical biomarkers in pituitary pathology. Endocr Pathol 29(2):130\u2013136","journal-title":"Endocr Pathol"},{"key":"518_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000514862","volume":"112","author":"A Spada","year":"2022","unstructured":"Spada A, Mantovani G, Lania Ag et al (2022) Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior. Neuroendocrinology 112:15\u201333","journal-title":"Neuroendocrinology"},{"key":"518_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3892\/ol.2015.3162","volume":"10","author":"X Yang","year":"2015","unstructured":"Yang X, Jiang Q, Yu B (2015) Solitary fibrous tumor located in the sella turcica: a report of two cases and review of the literature. Oncol Lett 10:354\u2013358","journal-title":"Oncol Lett"},{"key":"518_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12022-016-9434-7","volume":"28","author":"Md Hyrcza","year":"2017","unstructured":"Hyrcza Md, Winer Da, Shago M et al (2017) Tfe3-expressing perivascular epithelioid cell neoplasm (Pecoma) of the sella turcica. Endocr Pathol 28:22\u201326","journal-title":"Endocr Pathol"},{"key":"518_CR19","doi-asserted-by":"publisher","first-page":"541626","DOI":"10.1155\/2012\/541626","volume":"2012","author":"Js Bleeker","year":"2012","unstructured":"Bleeker Js, Quevedo Jf, Folpe Al (2012) \u201cMalignant\u201d perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 2012:541626","journal-title":"Sarcoma"},{"key":"518_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000510241","volume":"98","author":"S Akumalla","year":"2020","unstructured":"Akumalla S, Madison R, Lin Di et al (2020) Characterization of clinical cases of malignant pecoma via comprehensive genomic profiling of DNA and RNA. Oncology 98:905\u2013912","journal-title":"Oncology"},{"key":"518_CR21","doi-asserted-by":"publisher","first-page":"9631","DOI":"10.3390\/ijms25179631","volume":"25","author":"C Lotsch","year":"2024","unstructured":"Lotsch C, Warta R, Herold-Mende C (2024) The molecular and immunological landscape of meningiomas. Int J Mol Sci 25:9631","journal-title":"Int J Mol Sci"},{"key":"518_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/his.12366","volume":"65","author":"A Agaimy","year":"2014","unstructured":"Agaimy A, Buslei R, Coras R et al (2014) Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel. Histopathology 65:60\u201370","journal-title":"Histopathology"},{"key":"518_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/neup.12408","volume":"38","author":"K Yoshimoto","year":"2018","unstructured":"Yoshimoto K, Hatae R, Suzuki So et al (2018) High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas. Neuropathology 38:3\u201310","journal-title":"Neuropathology"},{"key":"518_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-013-1117-6","volume":"125","author":"L Schweizer","year":"2013","unstructured":"Schweizer L, Koelsche C, Sahm F et al (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the Nab2-Stat6 fusion and can be diagnosed by nuclear expression of stat6 protein. Acta Neuropathol 125:651\u2013658","journal-title":"Acta Neuropathol"},{"issue":"8","key":"518_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/1066896915591272","volume":"23","author":"J Shen","year":"2015","unstructured":"Shen J, Shrestha S, Yen Yh et al (2015) Pericyte antigens in perivascular soft tissue tumors. Int J Surg Pathol 23(8):638\u2013648","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"518_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200101000-00001","volume":"25","author":"Al Folpe","year":"2001","unstructured":"Folpe Al, Fanburg-Smith Jc, Miettinen M, Weiss Sw (2001) Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol 25(1):1\u201312","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"518_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3748\/wjg.v26.i7.770","volume":"26","author":"Jh Chen","year":"2020","unstructured":"Chen Jh, Lin L, Liu Kl et al (2020) Malignant glomus tumor of the intestinal ileum with multiorgan metastases: a case report and review of literature. World J Gastroenterol 26(7):770\u2013776","journal-title":"World J Gastroenterol"},{"issue":"11","key":"518_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/jcp.51.11.872","volume":"51","author":"L Hegyi","year":"1998","unstructured":"Hegyi L, Cormack Gc, Grant Jw (1998) Histochemical investigation into the molecular mechanisms of malignant transformation in a benign glomus tumour. J Clin Pathol 51(11):872\u2013874","journal-title":"J Clin Pathol"},{"issue":"11","key":"518_CR29","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/PAS.0000000000000913","volume":"41","author":"N Karamzadeh Dashti","year":"2017","unstructured":"Karamzadeh Dashti N, Bahrami A, Lee Sj et al (2017) Braf V600e mutations occur in a subset of glomus tumors, and are associated with malignant histologic characteristics. Am J Surg Pathol 41(11):1532\u20131541","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"518_CR30","doi-asserted-by":"publisher","first-page":"E231476","DOI":"10.1001\/jamanetworkopen.2023.1476","volume":"6","author":"X Hy","year":"2023","unstructured":"Hy X, Rq S, Jx Z et al (2023) Association of Braf variants with disease characteristics, prognosis, and targeted therapy response in intrahepatic cholangiocarcinoma. Jama Netw Open 6(3):E231476","journal-title":"Jama Netw Open"},{"issue":"2","key":"518_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17691\/stm2022.14.2.04","volume":"14","author":"Op Dribnokhodova","year":"2022","unstructured":"Dribnokhodova Op, Esman As, Korchagin Vi et al (2022) A complex of pyrosequencing-based methods for detection of somatic mutations in codons 600 and 601 of the BRAF gene. Sovrem Technol Med 14(2):41\u201349","journal-title":"Sovrem Technol Med"},{"issue":"6892","key":"518_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell Gr, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u2013954","journal-title":"Nature"},{"key":"518_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2015.0227","volume":"26","author":"M Afkhami","year":"2016","unstructured":"Afkhami M, Karunamurthy A, Chiosea S et al (2016) Histopathologic and clinical characterization of thyroid tumors carrying the Braf(K601e) mutation. Thyroid 26:242\u2013247","journal-title":"Thyroid"},{"issue":"2","key":"518_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000500481","volume":"12","author":"Fv Moiseyenko","year":"2019","unstructured":"Moiseyenko Fv, Egorenkov Vv, Kramchaninov Mm et al (2019) Lack of response to Vemurafenib in melanoma carrying Braf K601e mutation. Case Rep Oncol 12(2):339\u2013343","journal-title":"Case Rep Oncol"},{"issue":"1","key":"518_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/annonc\/mdt495","volume":"25","author":"T Kinno","year":"2014","unstructured":"Kinno T, Tsuta K, Shiraishi K et al (2014) Clinicopathological features of nonsmall cell lung carcinomas with Braf mutations. Ann Oncol 25(1):138\u2013142","journal-title":"Ann Oncol"},{"key":"518_CR36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"Pt Wan","year":"2004","unstructured":"Wan Pt, Garnett Mj, Roe Sm et al (2004) Mechanism of activation of the Raf-Erk signaling pathway by oncogenic mutations of B-Raf. Cell 116:855\u2013867","journal-title":"Cell"},{"key":"518_CR37","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccell.2015.08.001","volume":"28","author":"Z Yao","year":"2015","unstructured":"Yao Z, Torres Nm, Tao A et al (2015) Braf mutants evade Erk-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition. Cancer Cell 28:370\u2013383","journal-title":"Cancer Cell"},{"issue":"22","key":"518_CR38","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.3390\/jcm12226970","volume":"12","author":"A Matrone","year":"2023","unstructured":"Matrone A, Citro F, Gambale C et al (2023) Braf K601e mutation in oncocytic carcinoma of the thyroid: a case report and literature review. J Clin Med 12(22):6970","journal-title":"J Clin Med"},{"issue":"5","key":"518_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/DAD.0b013e31823931b4","volume":"34","author":"A Chakrapani","year":"2012","unstructured":"Chakrapani A, Warrick A, Nelson D, Beadling C, Corless CL (2012) Braf and Kras mutations in sporadic glomus tumors. Am J Dermatopathol 34(5):533\u2013535","journal-title":"Am J Dermatopathol"},{"key":"518_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-017-0067-4","volume":"6","author":"R Marconcini","year":"2017","unstructured":"Marconcini R, Galli L, Antonuzzo A et al (2017) Metastatic Braf K601e-mutated melanoma reaches complete response to mek inhibitor trametinib administered for over 36 months. Exp Hematol Oncol 6:6","journal-title":"Exp Hematol Oncol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-025-00518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-025-00518-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-025-00518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:01:34Z","timestamp":1784196094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-025-00518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s10014-025-00518-y","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest regarding the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this article does not contain any interventional studies with human or animal subjects. Oral informed consent was obtained from the patients.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this article does not contain any clinical trials.","order":3,"name":"Ethics","label":"Trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}